Login

Clinical Trials for Special Populations - Dr. Robert Jacobson, a Professor of Pediatric and Adolescent Medicine 00:00:00

Share On Facebook Share On Twitter

Clinical Trials for Special Populations

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Exploration Update: PolarX Advances Alaska Range Project
00:10:00
Why Choose Dunn Capital Management?
00:10:00
Dr. Amit Varma on Private Equity's Role in Transforming Healthcare | Amit Varma, Managing Partner, Quadria Capital.
00:10:00
In this video, Lorenzo presents the various types of electronic signatures, their characteristics, and their legal significance, especially under the new eIDAS regulation.||Sergio Muratori Casali is Founder & Co-CEO of Doxee SpA
00:10:00
Rethinking Tradition: Roger Kruse on IRS Practices | Roger C. Kruse - principal and founding partner of FFP Wealth Management
00:10:00
Stanley Kurtz on Obama's Socialist Roots and Radical Influences
00:10:00
"From Tax Law to Real Estate: A Decade of Opportunity with Bridge Investment Group"|CFO,Bridge Investment Group Holdings Inc
00:10:00
private equity deals focused on emerging restaurants beverages services|Don Thompson,CEO,Cleveland Avenue
00:10:00
Empowering Digital Success: Josh Greene on Tools, Tactics, and Growth in Marketing | Josh Green, CEO,The Mather Group.
00:10:00
Resolute Mining: CEO Terry Hulahan on Overcoming Challenges and Gold Production Growth in West Africa|Terry Holohan,Managing Director and Chief Executive Officer,Resolute Mining Ltd.
00:10:00
Quick High-Level Valuation of Kelly Partners Group: Is It Worth a Deeper Dive?
00:10:00
Meet the CEOs: Navigating the Structure of a Combined Business with Martin Gilbert

© 2026 Nehu